Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced scientific research and produces modern drugs. The company also conducts effective marketing of its own products. Our drugs help thousands of patients to live better and longer lives.
Meet our pipeline
Meet our pipelineWe create
innovative drugs, that will change
the lives of patients globally
- CBITEPreclinical and clinical development of a first-in-class, innovative, bispecific immunotherapeutic agent as a drug candidate in cancer immunotherapy
- CITYDevelopment of an innovative, class-leading, low-molecular, double-oriented therapeutic agent having immunomodulating and cytotoxic effects as a drug candidate for theRead more »
- BAAPDevelopment of an innovative platform for the production of bispecific constructions based on Phage Display technique and the preclinical andRead more »
- KICHAIPreclinical and clinical development of the innovative PI3 delta kinase inhibitor as a candidate in the treatment of inflammatory diseases
- Implemented projectsImplemented projects
- TrackBTrackB - Preclinical and clinical development of innovative TrkB antagonist in treatment of nervous system disorders.
- UBAUBA – Preclinical and clinical development of the ubiquitin-proteasome system inhibitor as an innovative drug used in cancer treatment.
- AMDBPAMDBP – Development of a production platform for biosimilars based on CHO cells and an innovative expression system and preclinicalRead more »
- GATEGATE – Preclinical and clinical development of an innovative antagonist of GPR40 receptor in type 2 diabetes treatment
- FAINDFAIND – A new diabetes treatment using an innovative FGF1 protein analogue.
- DISKA new form of S-ketamine in treatment of depression
- PIKCelPIKCel – developing inhalation technology in asthma and COPD treatment
- NoteSzHDNoteSzHD – "New therapy in psychotic disorders and Huntington's disease with special focus on cognitive deficits" .
- NATcoNATco – "New anti-amyloid therapy for cognitive disorders"
- CELONKOCELONKO – "Development of modern biomarkers and development of an innovative FGFR kinases inhibitor"
- JAKSONJAKSON – Selective JAK/ROCK kinases inihibitor in treatment of immune-mediated diseases
- RDC“Fostering Celon Pharma S.A. research infrastructure by creating a Research&Development Centre (RDC)”
Our Research and Development Center
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry.
We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative
publications and articles